Study of decade-long leukemia remissions after Car T reveals new details about persistence of personalized cells
In the summer of 2010, Bill Ludwig and Doug Olson were battling an insidious blood cancer called chronic lymphocytic leukemia (CLL). They'd both received numerous treatments, and as remaining options became scarce, they volunteered ...
Feb 2, 2022
0
51